Cancer Therapeutic Targets

Buch | Hardcover

1105 Seiten

2017 | 1st ed. 2017
Springer-Verlag New York Inc.
978-1-4419-0716-5 (ISBN)

Artikel merken

In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these successes, innumerable new targets and new potential therapeutics are being developed by many different groups including government agencies, pharmaceutical companies, biotechnology companies, academic institutions, and individual investigators. Understanding the expanding "universe" of cancer therapies is therefore becoming impossible and no single source exists which serves as a reference for the involved parties. Further, the interested parties have vastly different areas of expertise, from focused laboratory based science, to clinical research, to corporate and regulatory oversight.

The text would be updated every two years, more often depending on pace of change, interest and sales. While useful online, this reference book would likely be kept in hard copy as well.

Editorial Board: John L. Marshall (Editor in Chief), Department of Hematology and Oncology, Otto J Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA Howard L. Kaufman, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA Lee M. Ellis, Department of Surgical Oncology and Molecular & Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA Louis M. Weiner, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington DC, USA Emanuel F Petricoin, Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Institute of Advanced Biomedical Research, Manassas, VA, USA Edward P. Gelmann, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA

Anti-angiogenic Targets

HER2/EGFR Targets

Nuclear Receptors

Hormone receptors

Heme surface markers

Other surface markers

Bcr/abl

Proteosome inhibitors

PPAR gamma

PARP

Methylation

Immune therapies

Cytokines

mTOR

wynt/apc

IGF, survival, PI3K, AKT

Reihe/Serie	Cancer Therapeutic Targets \| 1.10
Zusatzinfo	64 Tables, color; 42 Illustrations, color; 9 Illustrations, black and white; XXXII, 1105 p. 51 illus., 42 illus. in color.
Verlagsort	New York, NY
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Laboratoriumsmedizin
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Studium
ISBN-10	1-4419-0716-5 / 1441907165
ISBN-13	978-1-4419-0716-5 / 9781441907165
Zustand	Neuware